JCP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Published Online First: 16 March 2007. doi:10.1136/jcp.2006.039263
Journal of Clinical Pathology 2007;60:1076-1085
Copyright © 2007 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jcp.2006.039263v1
60/10/1076    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Prakash, S.
Right arrow Articles by Swerdlow, S. H
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prakash, S.
Right arrow Articles by Swerdlow, S. H
Related Collections
Right arrow Editor's choice

MY APPROACH

Nodal aggressive B-cell lymphomas: a diagnostic approach

Sonam Prakash, Steven H Swerdlow

Division of Hematopathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA

Correspondence to:
Dr Steven H Swerdlow, Division of Hematopathology, University of Pittsburgh School of Medicine, UPMC-Presbyterian, Room C606, 200 Lothrop Street, Pittsburgh, PA 15213, USA; swerdlowsh{at}upmc.edu


ABSTRACT
The diffuse aggressive B-cell lymphomas, as recognised in the 2001 WHO classification, represent a clinically and biologically heterogeneous group of neoplasms that require very different therapeutic approaches and have very different outcomes. They should be diagnosed using a multiparameter approach that emphasises morphological and immunophenotypic studies, and in at least some cases, relies on cytogenetic and/or genotypic studies. Incorporation of clinical data may be important as well. There is also current interest in going beyond the basic diagnosis and providing pathological prognostic information when possible. Whereas the diagnosis of some cases will be relatively easy, the differential diagnosis in others is very difficult, with some cases in a grey zone between two different well defined categories.


Keywords: aggressive B-cell lymphoma; B-cell lymphoma; Burkitt lymphoma; diffuse large cell lymphoma; high grade B-cell lymphoma







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Journal of Clinical Pathology Molecular Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2007 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.